Elanco Animal Health Incorporated Restructuring Charges
Elanco Animal Health Incorporated (ELAN) reported Restructuring Charges of $2.00 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2026-08-05
- Elanco Animal Health Incorporated restructuring charges for the quarter ending 2026-06-30 was $3.00M.
- Elanco Animal Health Incorporated restructuring charges for the quarter ending 2026-03-31 was -$1.00M, a 200.00% decline year-over-year.
- Elanco Animal Health Incorporated restructuring charges for the quarter ending 2025-12-31 was $155.00M.
- Elanco Animal Health Incorporated restructuring charges for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Elanco Animal Health Incorporated restructuring charges for fiscal 2025 was $156.00M, a 254.55% increase from fiscal 2024.
- Elanco Animal Health Incorporated restructuring charges for fiscal 2024 was $44.00M.
- Elanco Animal Health Incorporated restructuring charges for fiscal 2023 was $0.00.
- Elanco Animal Health Incorporated restructuring charges for fiscal 2022 was -$7.00M, a 106.36% decline from fiscal 2021.
| Period end | Restructuring Charges 3 month | Restructuring Charges 3 month as first filed | Restructuring Charges 6 month | Restructuring Charges 6 month as first filed | Restructuring Charges 9 month | Restructuring Charges 9 month as first filed | Restructuring Charges 12 month | Restructuring Charges 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $2.00M 10-Q · filed 2026-08-05 | $157.00M derived: sum of 3 quarters · filed 2026-08-05 | $157.00M derived: sum of 4 quarters · filed 2026-08-05 | ||||
| 2026-03-31 | -$1.00M 10-Q · filed 2026-05-06 | $154.00M derived: sum of 2 quarters · filed 2026-05-06 | $154.00M derived: sum of 3 quarters · filed 2026-05-06 | $154.00M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2025-12-31 | $155.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $155.00M derived: sum of 2 quarters · filed 2026-02-24 | $155.00M derived: sum of 3 quarters · filed 2026-02-24 | $156.00M 10-K · filed 2026-02-24 | ||||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-05 | $0.00 derived: sum of 2 quarters · filed 2025-11-05 | $1.00M 10-Q · filed 2025-11-05 | $0.00 derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 | $1.00M 10-Q · filed 2025-08-07 | $0.00 derived: sum of 3 quarters · filed 2026-02-24 | $2.00M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2025-03-31 | $1.00M 10-Q · filed 2025-05-07 | $0.00 derived: sum of 2 quarters · filed 2026-02-24 | $2.00M derived: sum of 3 quarters · filed 2026-02-24 | $6.00M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-12-31 | -$1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $1.00M derived: sum of 2 quarters · filed 2026-02-24 | $5.00M derived: sum of 3 quarters · filed 2026-02-24 | $44.00M 10-K · filed 2026-02-24 | ||||
| 2024-09-30 | $2.00M 10-Q · filed 2025-11-05 | $6.00M derived: sum of 2 quarters · filed 2025-11-05 | $45.00M 10-Q · filed 2025-11-05 | $45.00M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-06-30 | $4.00M 10-Q · filed 2025-08-07 | $43.00M 10-Q · filed 2025-08-07 | $43.00M derived: sum of 3 quarters · filed 2026-02-24 | $43.00M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2024-03-31 | $39.00M 10-Q · filed 2025-05-07 | $39.00M derived: sum of 2 quarters · filed 2026-02-24 | $39.00M derived: sum of 3 quarters · filed 2026-02-24 | $39.00M derived: sum of 4 quarters · filed 2026-02-24 | ||||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | $0.00 derived: sum of 2 quarters · filed 2026-02-24 | $0.00 derived: sum of 3 quarters · filed 2026-02-24 | $0.00 10-K · filed 2026-02-24 | ||||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-07 | $0.00 derived: sum of 2 quarters · filed 2024-11-07 | $0.00 10-Q · filed 2024-11-07 | $0.00 derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-08 | $0.00 10-Q · filed 2024-08-08 | $0.00 derived: sum of 3 quarters · filed 2025-02-25 | $0.00 derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-08 | $0.00 derived: sum of 2 quarters · filed 2025-02-25 | $0.00 derived: sum of 3 quarters · filed 2025-02-25 | -$1.00M derived: sum of 4 quarters · filed 2025-02-25 | ||||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $0.00 derived: sum of 2 quarters · filed 2025-02-25 | -$1.00M derived: sum of 3 quarters · filed 2025-02-25 | -$7.00M 10-K · filed 2025-02-25 | ||||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-07 | -$1.00M derived: sum of 2 quarters · filed 2023-11-07 | -$7.00M 10-Q · filed 2023-11-07 | |||||
| 2022-06-30 | -$1.00M 10-Q · filed 2023-08-07 | -$7.00M 10-Q · filed 2023-08-07 | ||||||
| 2021-12-31 | $69.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | $68.00M derived: sum of 2 quarters · filed 2024-02-26 | $71.00M derived: sum of 3 quarters · filed 2024-02-26 | $110.00M 10-K · filed 2024-02-26 | $126.00M 10-K · filed 2022-02-28 | |||
| 2021-09-30 | -$1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $2.00M derived: sum of 2 quarters · filed 2021-11-05 | $41.00M 10-Q · filed 2021-11-05 | $65.00M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2021-06-30 | $3.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $42.00M 10-Q · filed 2021-08-09 | $66.00M derived: sum of 3 quarters · filed 2022-02-28 | $196.00M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2021-03-31 | $39.00M 10-Q · filed 2021-05-07 | $63.00M derived: sum of 2 quarters · filed 2022-02-28 | $193.00M derived: sum of 3 quarters · filed 2022-02-28 | $194.00M derived: sum of 4 quarters · filed 2022-02-28 | ||||
| 2020-12-31 | $24.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $154.00M derived: sum of 2 quarters · filed 2022-02-28 | $155.00M derived: sum of 3 quarters · filed 2022-02-28 | $157.00M 10-K · filed 2022-02-28 | $156.50M 10-K · filed 2021-03-01 | |||
| 2020-09-30 | $130.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05 | $131.00M derived: sum of 2 quarters · filed 2021-11-05 | $133.00M 10-Q · filed 2021-11-05 | $132.60M 10-Q · filed 2020-11-06 | $111.60M derived: sum of 4 quarters · filed 2021-11-05 | |||
| 2020-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $3.00M 10-Q · filed 2021-08-09 | $2.40M 10-Q · filed 2020-07-30 | -$18.40M derived: sum of 3 quarters · filed 2021-08-09 | $19.80M derived: sum of 4 quarters · filed 2021-08-09 | |||
| 2020-03-31 | $2.00M 10-Q · filed 2021-05-07 | $1.60M 10-Q · filed 2020-05-07 | -$19.40M derived: sum of 2 quarters · filed 2021-05-07 | $18.80M derived: sum of 3 quarters · filed 2021-05-07 | $20.80M derived: sum of 4 quarters · filed 2021-05-07 | |||
| 2019-12-31 | -$21.40M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $16.80M derived: sum of 2 quarters · filed 2021-03-01 | $18.80M derived: sum of 3 quarters · filed 2021-03-01 | $19.30M 10-K · filed 2021-03-01 | ||||
| 2019-09-30 | $38.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $40.20M derived: sum of 2 quarters · filed 2020-11-06 | $40.70M 10-Q · filed 2020-11-06 | $59.50M derived: sum of 4 quarters · filed 2020-11-06 | ||||
| 2019-06-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-30 | $2.50M 10-Q · filed 2020-07-30 | $21.30M derived: sum of 3 quarters · filed 2020-07-30 | $8.50M derived: sum of 4 quarters · filed 2020-07-30 | ||||
| 2019-03-31 | $500.00K 10-Q · filed 2020-05-07 | $19.30M derived: sum of 2 quarters · filed 2020-05-07 | $6.50M derived: sum of 3 quarters · filed 2020-05-07 | $27.60M derived: sum of 4 quarters · filed 2020-05-07 | ||||
| 2018-12-31 | $18.80M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $6.00M derived: sum of 2 quarters · filed 2020-02-28 | $27.10M derived: sum of 3 quarters · filed 2020-02-28 | $27.20M 10-K · filed 2020-02-28 | ||||
| 2018-09-30 | -$12.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $8.30M derived: sum of 2 quarters · filed 2019-11-08 | $8.40M 10-Q · filed 2019-11-08 | $115.80M derived: sum of 4 quarters · filed 2019-11-08 | ||||
| 2018-06-30 | $21.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $21.20M 10-Q · filed 2019-08-13 | $128.60M derived: sum of 3 quarters · filed 2019-08-13 | |||||
| 2018-03-31 | $100.00K 10-Q · filed 2019-05-14 | $107.50M derived: sum of 2 quarters · filed 2019-05-14 | ||||||
| 2017-12-31 | $107.40M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $193.80M 10-K · filed 2019-02-20 | ||||||
| 2017-09-30 | $86.40M 10-Q · filed 2018-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |